RET基因在肿瘤中的研究现状和展望

doi:10.11904/j.issn.1002-3070.2015.05.018

Abstract

Abstract: To review recent studies on the research advance of RET(Rearranged during transfection)oncogene in thyroid cancer,breast cancer,and lung cancer.The literatures on the structure of RET gene and coding product,cell signal transduction,relationship among thyroid cancer,breast cancer,and lung cancer are reviewed.RET gene encoding tyrosine kinase receptor,involving in cell signal transduction,rearrangement of RET gene is frequently seen in thyroid cancer,which is reported more and more in breast cancer,and lung cancer.Rearrangement of RET gene is closely correlated with the occurrence and progress of thyroid cancer,breast cancer,and lung cancer.Taking together,these findings suggest that RET present an attractive therapeutic target for the treatment of certain cancer subsets.

Key words: RET, Thyroid cancer, Breast cancer, Lung cancer

CLC Number:

R73-31

SUN Ji, MIAO Susheng, PEI Rong, MAO Xionghui. Research of RET in cancer:Current and future[J]. PRACTICAL ONCOLOGY JOURNAL, 2015, 29(5): 467-470.

References

1 Takahashi M,Ritz J,Cooper GM.Activation of a novel human transforming gene ret by DNA rearrangement[J].Cell,1985,42(2):581-588.
2 Pasini B,Hofstra RM,Yin L,et al.The physical map of the human RET proto-oncogene[J].Oncogene,1995,11(9):1737-1741.
3 Daniela Califano D,Rizzo CD,Alessio A,et al.Signaling through Ras is essential for Ret oncogene-induced cell differentiation in PCI2 cells[J].J Biol Chem,2000,275(25):19297-19305.
4 Mai KT,Lanary DC,Thomas J,et al.Ret oncogene protein expression in papillary thyroid carcinoma and related lesions[J].Tumor,2001,87(3):166-172.
5 Besset V,Scott RP,Ibanez CF,et al.Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase[J].J Biol Chem,2000,275(50):39159-39164.
6 Plaza-Menacho I,Burzynski GM,de Groot JW,et al.Current concepts in RET-related genetics,signaling and therapeutics[J].Trends Genet,2006,22(11):627-636.
7 Iwashita T,Kato M,Murakami H,et al.Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma[J].Oncogene,1999,18(26):3919-3922.
8 唐波,姜军.RET/PTC3基因重排在甲状腺癌中的作用机制及研究进展[J].中华实验外科杂志,2013,30(10):2241-2242.
9 苗素生,孙冀,裴荣.RET和VEGF-C在甲状腺乳头状癌中表达的研究[J].实用肿瘤学杂志,2010,(24)4:373-377.
10 Esseghir S,Todd SK,Hunt T,et al,A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer[J].Cancer Res,2007,67(24):11732-11741.
11 Borrello MG,Alberti L,Arighi E,et al.The full oncogenic activity of Ret/ptc2 depends on tyrosine 539,a Docking site for phospholipase C gamma[J].Mol Cell Biol,1996,16(5):2151-2163.
12 Kang J,Qian PX,Pandey V,et al.Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma[J].Oncogene,2010,29(22):3228-3240.
13 Spanheimer PM,Cyr AR,Gillum MP,et al.Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy[J].Ann Surg,2014,259(4):793-799.
14 Gattelli A,Nalvarte I,Boulay A,et al.Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells[J].Embo Mol Med,2013,5(9):1335-1350.
15 Ju YS,Lee WC,Shin JY,et al.A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing[J].Genome Res,2012,22(3):436-445.
16 Kohno T,Ichikawa H,Totoki Y,et al.KIF5B-RET fusions in lung adenocarcinoma[J].Nat Med,2012,18(10):375-377.
17 Lipson D,Capelletti M,Yelensky R,et al.Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies[J].Nat Med,2012,18(3):382-384.
18 Drilon A,Wang L,Hasanovic A,et al.Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas[J].Cancer Discov,2013,3(6):630-635.
19 Gainor JF,Shaw AT.The new kid on the block:RET in lung cancer[J].Cancer Discov,2013,3(6):604-606.
20 Gainor JF,Shaw AT.Novel targets in non-small cell lung cancer:ROS1 and RET fusions[J].Oncologist,2013,18(7):865-875.
21 Wedge SR,Ogilvie DJ,Dukes M,et al.ZD6474 inhibits vascular endothelial growth factor signaling,angiogenesis,and tumor growth following oral administration[J].Cancer Res,2002,62(16):4645-4655.
22 Wells Jr SA,Robinson BG,Gagel RF,et al.Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer:a randomized,double-blind phase III trial[J].J Clin Oncol,2012,30(2):134-141.

[1]	ZHANG Jiawen,YU Yan,ZHANG Wei,CAO Jingyan,LUO Wen,SHANG Lihua. Serum metabolomics of small cell lung cancer patients based on UPLC-TOF/MS [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 200-205.
[2]	WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.
[3]	LIU Zhiqiang,CHU Yanjie,LIU Jing,WANG Yanbo. Atractylenolide I regulates proliferation and invasion of lung cancer A549 cells through the TLR4/MyD88 pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 228-232.
[4]	LI Shuo,ZHANG Nannan,LI Liangliang,LONG Zhiping,YIN Huihui,ZHAO Yashuang,WANG Fan. Relationship between PDE4C gene methylation in peripheral blood leukocytes,interaction of environmental factors and pathogenesis of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 233-238.
[5]	ZHANG Yanqiu,HAN Ameng,LI Jinwang,GU Tao,FU Zhanzhao,MAO Yu,ZHANG Zijian,YANG Zhen. The preliminary study on clinical application of CRT+ARC technique in patients with locally advanced lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 256-260.
[6]	CHEN Yanbo, KONG Dejia, ZHANG Jinfeng, MA Zhigang. Correlation between CYP2D6 gene polymorphism and tamoxifen metabolism in breast cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 110-114.
[7]	SUN Jianghong, HAO Mingzhu, JIANG Dan, GUO Fei, LI Xiaomei. FFDM differential diagnosis of mastitis,benign hyperplasia and breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 139-141.
[8]	ZHAO Su, ZHENG Xiaoyu, ZHU Kaibin, BU Jianlong, XU Shidong. Effect of complete lung cancer resection on the balance of Th17/Treg in the peripheral blood of patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 142-148.
[9]	MA Zhijie, WANG Fan, ZHAO Yashuang. Analysis of life quality and influencing factors in breast cancer patients with chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 149-154.
[10]	MA Zhingying, SHANG Naijian, CAI Miaotian, SHEN Yang, JIANG Zhiyun. Correlation between HER-2 receptor of progesterone and estrogen receptor-positive breast cancer and mammography imaging & clinicopathological features [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 47-51.
[11]	HU Zhihui, ZHANG Jing. Research progress in the prediction of SNP on radiation-induced lung injury [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 87-91.
[12]	MULALI Dina, HU Xin, TUOHAYI Jiazina. The application and prospect of telemedicine in lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 555-557.
[13]	LI Wanzhen, YIN Jun, LI Ping, LIN Xiaohui, ZHANG Guoqian, ZHANG Shuxu. The expression and role of miR-17 in radioresistant cells of non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 391-397.
[14]	HE Xu, YE shangmian, DONG dandan, LI Ke. The expression of HLA-G in breast cancer and its significance [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 410-414.
[15]	CAI Jing, HOU Yue. The expression and clinical significance of serum miR-195 in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 415-419.

Research of RET in cancer:Current and future

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments